Mh. Andersen et al., Spontaneous cytotoxic T-cell responses against survivin-derived MHC class I-restricted T-cell epitopes in situ as well as ex vivo in cancer patients, CANCER RES, 61(16), 2001, pp. 5964-5968
Recent advances in therapeutic tumor vaccinations necessitate the identific
ation of broadly expressed, immunogenic tumor antigens that are not prone t
o immune selection. To this end, the human inhibitor of apoptosis, survivin
, is a prime candidate because it is expressed in most human neoplasms but
not in normal, differentiated tissues. Here, we demonstrate spontaneous cyt
otoxic T-cell responses against survivin-derived MHC class I-restricted T-c
ell epitopes in breast cancer, leukemia, and melanoma patients both in situ
as well as ex vivo. Moreover, survivin-reactive T cells isolated by magnet
ic beads coated with MHC/peptide complexes were cytotoxic against HLA-match
ed tumors of different tissue types. Being a universal tumor antigen, survi
vin may serve as a widely applicable target for anticancer immunotherapy.